DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,112,000 | -52.7% | 700,000 | -12.5% | 0.32% | -47.9% |
| Q2 2021 | $29,856,000 | +46.0% | 800,000 | 0.0% | 0.61% | +67.9% |
| Q1 2021 | $20,456,000 | +85.7% | 800,000 | +60.0% | 0.36% | -15.3% |
| Q4 2019 | $11,015,000 | -23.3% | 500,000 | -50.0% | 0.43% | -26.0% |
| Q3 2019 | $14,360,000 | -8.8% | 1,000,000 | 0.0% | 0.58% | -9.6% |
| Q2 2019 | $15,750,000 | +9.8% | 1,000,000 | +2.1% | 0.64% | +8.7% |
| Q1 2019 | $14,346,000 | +155.6% | 979,275 | +86.5% | 0.59% | +181.7% |
| Q4 2018 | $5,612,000 | -13.5% | 525,000 | +23.5% | 0.21% | +23.1% |
| Q3 2018 | $6,486,000 | +24.6% | 425,000 | 0.0% | 0.17% | +52.3% |
| Q2 2018 | $5,206,000 | +28.1% | 425,000 | 0.0% | 0.11% | +117.6% |
| Q1 2018 | $4,063,000 | – | 425,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $89,888,000 | 13.40% |
| EcoR1 Capital, LLC | 3,627,597 | $79,916,000 | 7.20% |
| Aquilo Capital Management, LLC | 614,436 | $13,536,000 | 5.08% |
| RTW INVESTMENTS, LP | 5,874,229 | $129,409,000 | 4.88% |
| BRIDGER MANAGEMENT, LLC | 1,981,633 | $43,655,000 | 3.15% |
| ACUTA CAPITAL PARTNERS, LLC | 387,500 | $8,537,000 | 2.11% |
| Integral Health Asset Management, LLC | 200,000 | $4,406,000 | 1.72% |
| Burrage Capital Management LLC | 104,047 | $2,292,000 | 1.54% |
| Parkman Healthcare Partners LLC | 240,000 | $5,287,000 | 1.53% |
| EAM Global Investors LLC | 122,237 | $2,693,000 | 1.08% |